These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35370072)

  • 1. Clinicopathological variables and risk factors for lung recurrence after resection of pancreatic ductal adenocarcinoma.
    Asakura Y; Toyama H; Ishida J; Asari S; Terai S; Shirakawa S; Yamashita H; Shimizu T; Ogura Y; Matsumoto I; Gon H; Tsugawa D; Komatsu S; Kuramitsu K; Yanagimoto H; Kido M; Ajiki T; Fukumoto T
    Asian J Surg; 2023 Jan; 46(1):207-212. PubMed ID: 35370072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
    Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
    Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of adjacent organ resection in patients with left-sided pancreatic ductal adenocarcinoma following distal pancreatectomy.
    Song KB; Kwon J; Kim YW; Hwang DW; Lee JH; Hong S; Lee JW; Hwang K; Yoo D; Kim SC
    J Hepatobiliary Pancreat Sci; 2019 Jun; 26(6):227-234. PubMed ID: 30980486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative prognosis of pancreatic cancer with para-aortic lymph node metastasis: a multicenter study on 822 patients.
    Sho M; Murakami Y; Motoi F; Satoi S; Matsumoto I; Kawai M; Honda G; Uemura K; Yanagimoto H; Kurata M; Fukumoto T; Akahori T; Kinoshita S; Nagai M; Nishiwada S; Unno M; Yamaue H; Nakajima Y
    J Gastroenterol; 2015 Jun; 50(6):694-702. PubMed ID: 25341657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study.
    Matsumoto I; Murakami Y; Shinzeki M; Asari S; Goto T; Tani M; Motoi F; Uemura K; Sho M; Satoi S; Honda G; Yamaue H; Unno M; Akahori T; Kwon AH; Kurata M; Ajiki T; Fukumoto T; Ku Y
    Pancreatology; 2015; 15(6):674-80. PubMed ID: 26467797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors Associated With Early Recurrence of Borderline Resectable Pancreatic Ductal Adenocarcinoma After Neoadjuvant Chemoradiation Therapy and Curative Resection.
    Tsuchiya N; Matsuyama R; Murakami T; Yabushita Y; Sawada YU; Kumamoto T; Endo I
    Anticancer Res; 2019 Aug; 39(8):4431-4440. PubMed ID: 31366541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left-sided pancreatic ductal adenocarcinoma.
    Kwon J; Lee SR; Park SY; Lee JH; Song KB; Hwang DW; Shin JH; Kim SC
    J Hepatobiliary Pancreat Sci; 2023 May; 30(5):633-643. PubMed ID: 36380718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
    Kim NH; Kim HJ
    Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection for liver recurrence after curative resection of pancreatic ductal adenocarcinoma.
    Shibata Y; Uemura K; Sumiyoshi T; Okada K; Otsuka H; Serikawa M; Ishii Y; Murakami Y; Arihiro K; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):280. PubMed ID: 37458812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative prediction of disease-free survival in pancreatic ductal adenocarcinoma patients after R0 resection using contrast-enhanced CT and CA19-9.
    Li D; Peng Q; Wang L; Cai W; Liang M; Liu S; Ma X; Zhao X
    Eur Radiol; 2024 Jan; 34(1):509-524. PubMed ID: 37507611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study.
    van Goor IWJM; Andel PCM; Buijs FS; Besselink MG; Bonsing BA; Bosscha K; Busch OR; Cirkel GA; van Dam RM; Festen S; Koerkamp BG; van der Harst E; de Hingh IHJT; Kazemier G; Liem MSL; Meijer G; de Meijer VE; Nieuwenhuijs VB; Roos D; Schreinemakers JMJ; Stommel MWJ; Wit F; Verdonk RC; van Santvoort HC; Molenaar IQ; Intven MPW; Daamen LA;
    Ann Surg Oncol; 2024 Nov; 31(12):8264-8275. PubMed ID: 38937412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Scand J Gastroenterol; 2019 Jun; 54(6):780-786. PubMed ID: 31180790
    [No Abstract]   [Full Text] [Related]  

  • 13. Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer.
    Okada K; Uemura K; Kondo N; Sumiyoshi T; Seo S; Otsuka H; Serikawa M; Ishii Y; Tsuboi T; Murakami Y; Takahashi S
    Pancreatology; 2021 Apr; 21(3):606-612. PubMed ID: 33648880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
    Groot VP; Rezaee N; Wu W; Cameron JL; Fishman EK; Hruban RH; Weiss MJ; Zheng L; Wolfgang CL; He J
    Ann Surg; 2018 May; 267(5):936-945. PubMed ID: 28338509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
    Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
    Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis.
    Kim JK; DePeralta DK; Ogami T; Denbo JW; Pimiento J; Hodul PJ; Malafa MP; Kim DW; Fleming JB; Powers BD
    J Surg Oncol; 2020 Nov; 122(6):1074-1083. PubMed ID: 32673436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of completion pancreatectomy for recurrence of adenocarcinoma in the remnant pancreas.
    Nakayama Y; Sugimoto M; Gotohda N; Konishi M; Takahashi S
    J Surg Res; 2018 Jan; 221():15-23. PubMed ID: 29229121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection.
    Murakawa M; Kawahara S; Takahashi D; Kamioka Y; Yamamoto N; Kobayashi S; Ueno M; Morimoto M; Sawazaki S; Tamagawa H; Ohshima T; Yukawa N; Rino Y; Morinaga S
    World J Surg Oncol; 2023 Aug; 21(1):263. PubMed ID: 37620940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma.
    Otsuka H; Uemura K; Kondo N; Sumiyoshi T; Nakagawa N; Okada K; Seo S; Murakami Y; Takahashi S
    Pancreatology; 2020 Oct; 20(7):1472-1478. PubMed ID: 32900632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineural Invasion of Pancreatic Ductal Adenocarcinoma is Associated with Early Recurrence after Neoadjuvant Therapy Followed by Resection.
    Cha DE; Yu AT; Khajoueinejad N; Gleeson E; Shaltiel T; Berger Y; Macfie R; Golas BJ; Sarpel U; Labow DM; Hiotis S; Cohen NA
    World J Surg; 2023 Jul; 47(7):1801-1808. PubMed ID: 37014430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.